アフターピル市販化の光と影—72時間競争と「人権侵害」の価格

緊急避妊薬ノルレボの市販化承認はSRHR実現に向けた歴史的進歩です。迅速なアクセス改善を評価する一方、医師として課題も指摘します。プライバシー侵害の懸念がある「面前服用」義務付けをどう捉えるか

Episode metadata supplied by the publisher feed · Published Oct 21, 2025

Embed this episode

Attribution link and audio player

Ready to play

アフターピル市販化の光と影—72時間競争と「人権侵害」の価格

0:00 7:07

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

No similar episodes found.

This episode is 7 minutes long.

This episode was published on October 21, 2025.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!